Nextremity Solutions Gains FDA Clearance For Lapidus Procedure

Nextremity Solutions received FDA 510(k) clearance to market the InCore™ Lapidus system for fusion of the first tarsometatarsal joint.

InCore Lapidus is a three-part construct intended for internal fixation for First Metatarsocuneiform Arthrodesis. An application...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us